Our new findings in this study demonstrate that stroke-induced activation of the SPAK–NKCC1 complex at the ChP is associated with barrier dysfunction, immune cell infiltration, activation of NF-κB and MMP9 signaling at the ChP. The gene discussed is STK39; the disease is stroke disorder.